Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Optimal timing and route of nutritional support after esophagectomy: A review of the literature.

Zheng R, Devin CL, Pucci MJ, Berger AC, Rosato EL, Palazzo F.

World J Gastroenterol. 2019 Aug 21;25(31):4427-4436. doi: 10.3748/wjg.v25.i31.4427. Review.

2.

Elastase 3B mutation links to familial pancreatitis with diabetes and pancreatic adenocarcinoma.

Moore PC, Cortez JT, Chamberlain CE, Alba D, Berger AC, Quandt Z, Chan A, Cheng MH, Bautista JL, Peng J, German MS, Anderson MS, Oakes SA.

J Clin Invest. 2019 Aug 1;130. pii: 129961. doi: 10.1172/JCI129961.

3.

Resection of Cavity Shave Margins in Stage 0-III Breast Cancer Patients Undergoing Breast Conserving Surgery: A Prospective Multicenter Randomized Controlled Trial.

Dupont E, Tsangaris T, Garcia-Cantu C, Howard-McNatt M, Chiba A, Berger AC, Levine EA, Gass JS, Gallagher K, Lum SS, Martinez RD, Willis AI, Pandya SV, Brown EA, Fenton A, Mendiola A, Murray M, Solomon NL, Senthil M, Ollila DW, Edmonson D, Lazar M, Namm JP, Li F, Butler M, McGowan NE, Herrera ME, Avitan YP, Yoder B, Walters LL, McPartland T, Chagpar AB.

Ann Surg. 2019 Jul 8. doi: 10.1097/SLA.0000000000003449. [Epub ahead of print]

PMID:
31290763
4.

Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.

Ecker BL, Vollmer CM Jr, Behrman SW, Allegrini V, Aversa J, Ball CG, Barrows CE, Berger AC, Cagigas MN, Christein JD, Dixon E, Fisher WE, Freedman-Weiss M, Guzman-Pruneda F, Hollis RH, House MG, Kent TS, Kowalsky SJ, Malleo G, Salem RR, Salvia R, Schmidt CR, Seykora TF, Zheng R, Zureikat AH, Dickson PV.

JAMA Surg. 2019 May 29. doi: 10.1001/jamasurg.2019.1170. [Epub ahead of print]

PMID:
31141112
5.

The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner.

Erkes DA, Field CO, Capparelli C, Tiago M, Purwin TJ, Chervoneva I, Berger AC, Hartsough EJ, Villanueva J, Aplin AE.

Pigment Cell Melanoma Res. 2019 Sep;32(5):687-696. doi: 10.1111/pcmr.12788. Epub 2019 May 20.

PMID:
31063649
6.

Patients with Non-response to Neoadjuvant Chemoradiation for Esophageal Cancer Have No Survival Advantage over Patients Undergoing Primary Esophagectomy.

Chevrollier GS, Giugliano DN, Palazzo F, Keith SW, Rosato EL, Evans Iii NR, Berger AC.

J Gastrointest Surg. 2019 Feb 26. doi: 10.1007/s11605-019-04161-9. [Epub ahead of print]

PMID:
30809782
7.

Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling.

Vetto JT, Hsueh EC, Gastman BR, Dillon LD, Monzon FA, Cook RW, Keller J, Huang X, Fleming A, Hewgley P, Gerami P, Leachman S, Wayne JD, Berger AC, Fleming MD.

Future Oncol. 2019 Apr;15(11):1207-1217. doi: 10.2217/fon-2018-0912. Epub 2019 Jan 29.

8.

Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells.

Gannon HS, Zou T, Kiessling MK, Gao GF, Cai D, Choi PS, Ivan AP, Buchumenski I, Berger AC, Goldstein JT, Cherniack AD, Vazquez F, Tsherniak A, Levanon EY, Hahn WC, Meyerson M.

Nat Commun. 2018 Dec 21;9(1):5450. doi: 10.1038/s41467-018-07824-4.

9.

Consecutive Case Series of Melanoma Sentinel Node Biopsy for Lymphoseek Compared to Sulfur Colloids.

Silvestri C, Christopher A, Intenzo C, Kairys JC, Kim S, Willis A, Berger AC.

J Surg Res. 2019 Jan;233:149-153. doi: 10.1016/j.jss.2018.07.042. Epub 2018 Aug 23.

PMID:
30502241
10.

A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily.

Korkut A, Zaidi S, Kanchi RS, Rao S, Gough NR, Schultz A, Li X, Lorenzi PL, Berger AC, Robertson G, Kwong LN, Datto M, Roszik J, Ling S, Ravikumar V, Manyam G, Rao A, Shelley S, Liu Y, Ju Z, Hansel D, de Velasco G, Pennathur A, Andersen JB, O'Rourke CJ, Ohshiro K, Jogunoori W, Nguyen BN, Li S, Osmanbeyoglu HU, Ajani JA, Mani SA, Houseman A, Wiznerowicz M, Chen J, Gu S, Ma W, Zhang J, Tong P, Cherniack AD, Deng C, Resar L; Cancer Genome Atlas Research Network, Weinstein JN, Mishra L, Akbani R.

Cell Syst. 2018 Oct 24;7(4):422-437.e7. doi: 10.1016/j.cels.2018.08.010. Epub 2018 Sep 26.

11.

Acquired disorders with depigmentation: A systematic approach to vitiliginoid conditions.

Saleem MD, Oussedik E, Schoch JJ, Berger AC, Picardo M.

J Am Acad Dermatol. 2019 May;80(5):1215-1231.e6. doi: 10.1016/j.jaad.2018.03.063. Epub 2018 Sep 17. Review.

PMID:
30236516
12.

ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.

Capparelli C, Purwin TJ, Heilman SA, Chervoneva I, McCue PA, Berger AC, Davies MA, Gershenwald JE, Krepler C, Aplin AE.

Cancer Res. 2018 Oct 1;78(19):5680-5693. doi: 10.1158/0008-5472.CAN-18-1001. Epub 2018 Aug 16.

13.

Utility of CT imaging in a novel form of high-dose-rate intraoperative breast radiation therapy.

Hassinger TE, Showalter TN, Schroen AT, Brenin DR, Berger AC, Libby B, Showalter SL.

J Med Imaging Radiat Oncol. 2018 Dec;62(6):835-840. doi: 10.1111/1754-9485.12790. Epub 2018 Aug 13.

PMID:
30102019
14.

Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer.

Viswanathan SR, Nogueira MF, Buss CG, Krill-Burger JM, Wawer MJ, Malolepsza E, Berger AC, Choi PS, Shih J, Taylor AM, Tanenbaum B, Pedamallu CS, Cherniack AD, Tamayo P, Strathdee CA, Lage K, Carr SA, Schenone M, Bhatia SN, Vazquez F, Tsherniak A, Hahn WC, Meyerson M.

Nat Genet. 2018 Jul;50(7):937-943. doi: 10.1038/s41588-018-0155-3. Epub 2018 Jun 28.

15.

A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.

Berger AC, Korkut A, Kanchi RS, Hegde AM, Lenoir W, Liu W, Liu Y, Fan H, Shen H, Ravikumar V, Rao A, Schultz A, Li X, Sumazin P, Williams C, Mestdagh P, Gunaratne PH, Yau C, Bowlby R, Robertson AG, Tiezzi DG, Wang C, Cherniack AD, Godwin AK, Kuderer NM, Rader JS, Zuna RE, Sood AK, Lazar AJ, Ojesina AI, Adebamowo C, Adebamowo SN, Baggerly KA, Chen TW, Chiu HS, Lefever S, Liu L, MacKenzie K, Orsulic S, Roszik J, Shelley CS, Song Q, Vellano CP, Wentzensen N; Cancer Genome Atlas Research Network, Weinstein JN, Mills GB, Levine DA, Akbani R.

Cancer Cell. 2018 Apr 9;33(4):690-705.e9. doi: 10.1016/j.ccell.2018.03.014. Epub 2018 Apr 2.

16.

Genomic and Functional Approaches to Understanding Cancer Aneuploidy.

Taylor AM, Shih J, Ha G, Gao GF, Zhang X, Berger AC, Schumacher SE, Wang C, Hu H, Liu J, Lazar AJ; Cancer Genome Atlas Research Network, Cherniack AD, Beroukhim R, Meyerson M.

Cancer Cell. 2018 Apr 9;33(4):676-689.e3. doi: 10.1016/j.ccell.2018.03.007. Epub 2018 Apr 2.

17.

Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.

Schaub FX, Dhankani V, Berger AC, Trivedi M, Richardson AB, Shaw R, Zhao W, Zhang X, Ventura A, Liu Y, Ayer DE, Hurlin PJ, Cherniack AD, Eisenman RN, Bernard B, Grandori C; Cancer Genome Atlas Network.

Cell Syst. 2018 Mar 28;6(3):282-300.e2. doi: 10.1016/j.cels.2018.03.003.

18.

Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas In Vivo and Ex Vivo.

Hartsough EJ, Kugel CH 3rd, Vido MJ, Berger AC, Purwin TJ, Goldberg A, Davies MA, Schiewer MJ, Knudsen KE, Bollag G, Aplin AE.

Mol Cancer Ther. 2018 Jan;17(1):84-95. doi: 10.1158/1535-7163.MCT-17-0705. Epub 2017 Nov 13.

19.

Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor.

Zhang X, Choi PS, Francis JM, Gao GF, Campbell JD, Ramachandran A, Mitsuishi Y, Ha G, Shih J, Vazquez F, Tsherniak A, Taylor AM, Zhou J, Wu Z, Berger AC, Giannakis M, Hahn WC, Cherniack AD, Meyerson M.

Cancer Discov. 2018 Jan;8(1):108-125. doi: 10.1158/2159-8290.CD-17-0532. Epub 2017 Sep 29.

20.

Genomic Activation of PPARG Reveals a Candidate Therapeutic Axis in Bladder Cancer.

Goldstein JT, Berger AC, Shih J, Duke FF, Furst L, Kwiatkowski DJ, Cherniack AD, Meyerson M, Strathdee CA.

Cancer Res. 2017 Dec 15;77(24):6987-6998. doi: 10.1158/0008-5472.CAN-17-1701. Epub 2017 Sep 18.

21.

Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies.

Ecker BL, McMillan MT, Maggino L, Allegrini V, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dickson E, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Salem RR, Soares KC, Valero V 3rd, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

J Gastrointest Surg. 2018 Jan;22(1):68-76. doi: 10.1007/s11605-017-3547-2. Epub 2017 Aug 24. No abstract available.

PMID:
28840459
22.

Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum.

Brown AM, Giugliano DN, Berger AC, Pucci MJ, Palazzo F.

Langenbecks Arch Surg. 2017 Dec;402(8):1153-1158. doi: 10.1007/s00423-017-1610-9. Epub 2017 Aug 12. Review.

PMID:
28803334
23.

Comparative Quantitative Lymph Node Assessment in Localized Esophageal Cancer Patients After R0 Resection With and Without Neoadjuvant Chemoradiation Therapy.

Giugliano DN, Berger AC, Pucci MJ, Rosato EL, Evans NR, Meidl H, Lamb C, Levine D, Palazzo F.

J Gastrointest Surg. 2017 Sep;21(9):1377-1384. doi: 10.1007/s11605-017-3478-y. Epub 2017 Jun 29.

PMID:
28664255
24.

A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeown.

Brown AM, Pucci MJ, Berger AC, Tatarian T, Evans NR 3rd, Rosato EL, Palazzo F.

Surg Endosc. 2018 Jan;32(1):204-211. doi: 10.1007/s00464-017-5660-4. Epub 2017 Jun 22.

PMID:
28643075
25.

Life perceptions of patients receiving palliative care and experiencing psycho-social-spiritual healing.

Li L, Sloan DH, Mehta AK, Willis G, Weaver MS, Berger AC.

Ann Palliat Med. 2017 Jul;6(3):211-219. doi: 10.21037/apm.2017.05.03. Epub 2017 Jun 3.

26.

Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy.

Ecker BL, McMillan MT, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Dickson EJ, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Javed AA, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Poruk KE, Salem RR, Schmidt CR, Soares K, Stauffer JA, Valero V, Velu LKP, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2018 Apr;267(4):608-616. doi: 10.1097/SLA.0000000000002327.

PMID:
28594741
27.

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM.

N Engl J Med. 2017 Jun 8;376(23):2211-2222. doi: 10.1056/NEJMoa1613210.

28.

Monitoring Neoadjuvant Chemotherapy for Breast Cancer by Using Three-dimensional Subharmonic Aided Pressure Estimation and Imaging with US Contrast Agents: Preliminary Experience.

Nam K, Eisenbrey JR, Stanczak M, Sridharan A, Berger AC, Avery T, Palazzo JP, Forsberg F.

Radiology. 2017 Oct;285(1):53-62. doi: 10.1148/radiol.2017161683. Epub 2017 May 3.

29.

Surgical Apgar score (SAS) predicts perioperative morbidity, mortality, and length of stay in patients undergoing esophagectomy at a high-volume center.

Giugliano DN, Morgan A, Palazzo F, Leiby BE, Evans NR, Rosato EL, Berger AC.

J Surg Oncol. 2017 Sep;116(3):359-364. doi: 10.1002/jso.24662. Epub 2017 May 2.

PMID:
28464255
30.

Do intraoperative pyloric interventions predict the need for postoperative endoscopic interventions after minimally invasive esophagectomy?

Giugliano DN, Berger AC, Meidl H, Pucci MJ, Rosato EL, Keith SW, Evans NR, Palazzo F.

Dis Esophagus. 2017 Apr 1;30(4):1-8. doi: 10.1093/dote/dow034.

PMID:
28375478
31.

Patient Symptoms Are the Most Frequent Indicators of Recurrence in Patients with American Joint Committee on Cancer Stage II Melanoma.

Berger AC, Ollila DW, Christopher A, Kairys JC, Mastrangelo MJ, Feeney K, Dabbish N, Leiby B, Frank JA, Stitzenberg KB, Meyers MO.

J Am Coll Surg. 2017 Apr;224(4):652-659. doi: 10.1016/j.jamcollsurg.2016.12.038. Epub 2017 Feb 8.

PMID:
28189663
32.

Total minimally invasive esophagectomy for esophageal cancer: approaches and outcomes.

Giugliano DN, Berger AC, Rosato EL, Palazzo F.

Langenbecks Arch Surg. 2016 Sep;401(6):747-56. doi: 10.1007/s00423-016-1469-1. Epub 2016 Jul 11. Review.

PMID:
27401326
33.

Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy.

McMillan MT, Allegrini V, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dickson E, Dixon E, Drebin JA, Fernandez-Del Castillo C, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, McElhany AL, Salem RR, Soares KC, Sprys MH, Valero V 3rd, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2017 May;265(5):978-986. doi: 10.1097/SLA.0000000000001796.

PMID:
27232260
34.

Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients.

Berger AC, Davidson RS, Poitras JK, Chabra I, Hope R, Brackeen A, Johnson CE, Maetzold DJ, Middlebrook B, Oelschlager KM, Cook RW, Monzon FA, Miller AR.

Curr Med Res Opin. 2016 Sep;32(9):1599-604. doi: 10.1080/03007995.2016.1192997. Epub 2016 Jun 3.

PMID:
27210115
35.

Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection.

Boland PM, Meyer JE, Berger AC, Cohen SJ, Neuman T, Cooper HS, Olszanski AJ, Davey M, Cheng JD, Lebenthal A, Burtness BA, Scott WJ, Astsaturov IA.

Am J Clin Oncol. 2017 Aug;40(4):393-398. doi: 10.1097/COC.0000000000000171.

36.

MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma.

Vu HL, Rosenbaum S, Capparelli C, Purwin TJ, Davies MA, Berger AC, Aplin AE.

J Invest Dermatol. 2016 Feb;136(2):453-463. doi: 10.1016/j.jid.2015.11.012. Epub 2015 Nov 20.

37.

Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not?

Tatarian T, Sokas C, Rufail M, Lazar M, Malhotra S, Palazzo JP, Hsu E, Tsangaris T, Berger AC.

Ann Surg Oncol. 2016 Aug;23(8):2501-7. doi: 10.1245/s10434-016-5182-7. Epub 2016 Mar 9.

PMID:
26960929
38.

Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation.

McMillan MT, Soi S, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, Miller BC, Salem RR, Soares K, Valero V, Wolfgang CL, Vollmer CM Jr.

Ann Surg. 2016 Aug;264(2):344-52. doi: 10.1097/SLA.0000000000001537.

PMID:
26727086
39.

Fibroblast-derived neuregulin 1 promotes compensatory ErbB3 receptor signaling in mutant BRAF melanoma.

Capparelli C, Rosenbaum S, Berger AC, Aplin AE.

J Biol Chem. 2015 Oct 2;290(40):24267-77. doi: 10.1074/jbc.M115.657270. Epub 2015 Aug 12.

40.

Making Personalized Health Care Even More Personalized: Insights From Activities of the IOM Genomics Roundtable.

David SP, Johnson SG, Berger AC, Feero WG, Terry SF, Green LA, Phillips RL Jr, Ginsburg GS.

Ann Fam Med. 2015 Jul-Aug;13(4):373-80. doi: 10.1370/afm.1772.

41.

Long-term functional outcomes of laparoscopic resection for gastric gastrointestinal stromal tumors.

Dressler JA, Palazzo F, Berger AC, Stake S, Chaudhary A, Chojnacki KA, Rosato EL, Pucci MJ.

Surg Endosc. 2016 Apr;30(4):1592-8. doi: 10.1007/s00464-015-4384-6. Epub 2015 Jul 14.

PMID:
26169640
42.

NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer.

Hong TS, Moughan J, Garofalo MC, Bendell J, Berger AC, Oldenburg NB, Anne PR, Perera F, Lee RJ, Jabbour SK, Nowlan A, DeNittis A, Crane C.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):29-36. doi: 10.1016/j.ijrobp.2015.05.005. Epub 2015 May 14.

43.

The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy.

McMillan MT, Vollmer CM Jr, Asbun HJ, Ball CG, Bassi C, Beane JD, Berger AC, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, McElhany AL, Salem RR, Soares K, Sprys MH, Valero V 3rd, Watkins AA, Wolfgang CL, Behrman SW.

J Gastrointest Surg. 2016 Feb;20(2):262-76. doi: 10.1007/s11605-015-2884-2. Epub 2015 Jul 11.

PMID:
26162925
44.

Global implementation of genomic medicine: We are not alone.

Manolio TA, Abramowicz M, Al-Mulla F, Anderson W, Balling R, Berger AC, Bleyl S, Chakravarti A, Chantratita W, Chisholm RL, Dissanayake VH, Dunn M, Dzau VJ, Han BG, Hubbard T, Kolbe A, Korf B, Kubo M, Lasko P, Leego E, Mahasirimongkol S, Majumdar PP, Matthijs G, McLeod HL, Metspalu A, Meulien P, Miyano S, Naparstek Y, O'Rourke PP, Patrinos GP, Rehm HL, Relling MV, Rennert G, Rodriguez LL, Roden DM, Shuldiner AR, Sinha S, Tan P, Ulfendahl M, Ward R, Williams MS, Wong JE, Green ED, Ginsburg GS.

Sci Transl Med. 2015 Jun 3;7(290):290ps13. doi: 10.1126/scitranslmed.aab0194. Review.

45.

Melanoma.

Berger AC.

Surg Oncol Clin N Am. 2015 Apr;24(2):xv-xvi. doi: 10.1016/j.soc.2015.01.001. No abstract available.

PMID:
25769720
46.

Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction.

Palazzo F, Rosato EL, Chaudhary A, Evans NR 3rd, Sendecki JA, Keith S, Chojnacki KA, Yeo CJ, Berger AC.

J Am Coll Surg. 2015 Apr;220(4):672-9. doi: 10.1016/j.jamcollsurg.2014.12.023. Epub 2014 Dec 27.

PMID:
25667145
47.

Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity.

Power A, Berger AC, Ginsburg GS.

JAMA. 2014 May;311(20):2063-4. doi: 10.1001/jama.2014.3002. No abstract available.

PMID:
24867009
48.

Contrast-enhanced sonography for detection of secondary lymph nodes in a melanoma tumor animal model.

Liu JB, Merton DA, Berger AC, Forsberg F, Witkiewicz A, Zhao H, Eisenbrey JR, Fox TB, Goldberg BB.

J Ultrasound Med. 2014 Jun;33(6):939-47. doi: 10.7863/ultra.33.6.939.

49.

Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial.

Shi W, Lawrence YR, Choy H, Werner-Wasik M, Andrews DW, Evans JJ, Judy KD, Farrell CJ, Moshel Y, Berger AC, Bar-Ad V, Dicker AP.

J Neurooncol. 2014 Jun;118(2):313-319. doi: 10.1007/s11060-014-1433-2. Epub 2014 Apr 13.

PMID:
24728831
50.

Panx1 regulates cellular properties of keratinocytes and dermal fibroblasts in skin development and wound healing.

Penuela S, Kelly JJ, Churko JM, Barr KJ, Berger AC, Laird DW.

J Invest Dermatol. 2014 Jul;134(7):2026-2035. doi: 10.1038/jid.2014.86. Epub 2014 Feb 12.

Supplemental Content

Loading ...
Support Center